{"title":"Imprinted X chromosome inactivation at the gamete-to-embryo transition.","authors":"Chunyao Wei, Barry Kesner, Hao Yin, Jeannie T Lee","doi":"10.1016/j.molcel.2024.02.013","DOIUrl":null,"url":null,"abstract":"<p><p>In mammals, dosage compensation involves two parallel processes: (1) X inactivation, which equalizes X chromosome dosage between males and females, and (2) X hyperactivation, which upregulates the active X for X-autosome balance. The field currently favors models whereby dosage compensation initiates \"de novo\" during mouse development. Here, we develop \"So-Smart-seq\" to revisit the question and interrogate a comprehensive transcriptome including noncoding genes and repeats in mice. Intriguingly, de novo silencing pertains only to a subset of Xp genes. Evolutionarily older genes and repetitive elements demonstrate constitutive Xp silencing, adopt distinct signatures, and do not require Xist to initiate silencing. We trace Xp silencing backward in developmental time to meiotic sex chromosome inactivation in the male germ line and observe that Xm hyperactivation is timed to Xp silencing on a gene-by-gene basis. Thus, during the gamete-to-embryo transition, older Xp genes are transmitted in a \"pre-inactivated\" state. These findings have implications for the evolution of imprinting.</p>","PeriodicalId":18950,"journal":{"name":"Molecular Cell","volume":" ","pages":"1442-1459.e7"},"PeriodicalIF":14.5000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11031340/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Cell","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.molcel.2024.02.013","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In mammals, dosage compensation involves two parallel processes: (1) X inactivation, which equalizes X chromosome dosage between males and females, and (2) X hyperactivation, which upregulates the active X for X-autosome balance. The field currently favors models whereby dosage compensation initiates "de novo" during mouse development. Here, we develop "So-Smart-seq" to revisit the question and interrogate a comprehensive transcriptome including noncoding genes and repeats in mice. Intriguingly, de novo silencing pertains only to a subset of Xp genes. Evolutionarily older genes and repetitive elements demonstrate constitutive Xp silencing, adopt distinct signatures, and do not require Xist to initiate silencing. We trace Xp silencing backward in developmental time to meiotic sex chromosome inactivation in the male germ line and observe that Xm hyperactivation is timed to Xp silencing on a gene-by-gene basis. Thus, during the gamete-to-embryo transition, older Xp genes are transmitted in a "pre-inactivated" state. These findings have implications for the evolution of imprinting.
在哺乳动物中,剂量补偿涉及两个平行过程:(1)X 失活,使雌雄之间的 X 染色体剂量相等;(2)X 超活化,使活性 X 上调,以实现 X-自体平衡。该领域目前倾向于在小鼠发育过程中 "从头 "启动剂量补偿的模型。在这里,我们开发了 "So-Smart-seq "来重新审视这个问题,并对包括小鼠非编码基因和重复序列在内的全面转录组进行了研究。耐人寻味的是,从头沉默只与一部分 Xp 基因有关。在进化过程中出现较早的基因和重复元件表现出组成型 Xp 沉默,具有不同的特征,并且不需要 Xist 来启动沉默。我们追溯了 Xp 沉默在雄性种系减数分裂性染色体失活过程中的发育时间,并观察到 Xm 的超活化与 Xp 沉默在基因上是同步的。因此,在配子到胚胎的转变过程中,较老的 Xp 基因是以 "预失活 "状态传递的。这些发现对印记的进化具有重要意义。
期刊介绍:
Molecular Cell is a companion to Cell, the leading journal of biology and the highest-impact journal in the world. Launched in December 1997 and published monthly. Molecular Cell is dedicated to publishing cutting-edge research in molecular biology, focusing on fundamental cellular processes. The journal encompasses a wide range of topics, including DNA replication, recombination, and repair; Chromatin biology and genome organization; Transcription; RNA processing and decay; Non-coding RNA function; Translation; Protein folding, modification, and quality control; Signal transduction pathways; Cell cycle and checkpoints; Cell death; Autophagy; Metabolism.